AMLYCAS

Trademark usage description

biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, onco Read More

Classification Information

Class [005]
Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes

Classification kind code

Mark Details

Serial Number

1890908

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 6 on 7^th Jan 2020	Abandoned - Section 36
Submitted for opposition 14 on 15^th Oct 2019	Default Notice Sent
Submitted for opposition 22 on 22^nd Mar 2019	Search Recorded
Submitted for opposition 20 on 22^nd Mar 2019	Examiner's First Report
Submitted for opposition 31 on 5^th Apr 2018	Formalized
Submitted for opposition 30 on 29^th Mar 2018	Filed
Submitted for opposition 1 on 29^th Mar 2018	Created